Home > Insider Trading > Filing (0001140361-19-012352)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1010086	Siga Technologies Inc	SIGA	Pharmaceutical Preparations (2834)	133864870

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1230974	J Michael Bayer	C/O Siga Technologies, Inc., 31 East 62Nd Street New York NY 10065		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $.0001 Per Share	Acquisiton	2013-09-17	8,284	$3.59	13,960	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Form 4 originally filed by the Reporting Person on September 18, 2013 overstated the number of shares purchased on September 17, 2013. As a result the number of shares beneficially owned following the transaction was also overstated on that filing and on each of the nine subsequent Forms 4 filed by the Reporting Person. This amendment corrects the number of shares purchased and the number of shares beneficially owned following the reported transaction as of September 17, 2013.
The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to SIGA Technologies, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.